ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer

This study is ongoing, but not recruiting participants.
Study NCT00083148.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00083148


Locations
United States, New York
Roswell Park Cancer Institute    
      Buffalo, New York, United States, 14263-0001

Sponsors and Collaborators
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Investigators
Principal Investigator:     Tracey O'Connor, MD     Roswell Park Cancer Institute    





Links to all studies - primarily for crawlers